CONSIDERATIONS TO KNOW ABOUT ABT-046

During the multiday, several-dose arm, baseline microbiota was equivalent amongst topics that received ibezapolstat in comparison with vancomycin. At Working day 10 of dosing, differential abundance Assessment and β-range shown a definite difference between the microbiome in subjects offered vancomycin in comparison with possibly dose of ibezapols